therapy with ethambutol was paused and switched to clo-
fazimine. With this therapy, the numbness and burning 
sensations did resolve. After a change of residence to the 
Netherlands owing to personal reasons, further care was 
provided there.
Until the end of the therapy in May 2022, numbness of 
the feet, joint pain, and dry skin remained as side effects. 
Even after discontinuation of the medication, the patient